Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications
JAMA · 2024
DOI: 10.1001/jama.2024.10023 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Marc Levi. Beteiligte Einrichtung: Department of Anesthesiology, University of North Carolina, Chapel Hill. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Respiratory Tract Diseases. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
In June 2023, the American Society of Anesthesiologists issued guidelines recommending preoperative withholding of glucagon-like peptide 1 receptor agonists (GLP-1RAs), used for type diabetes management and weight loss. These guidelines, which have been questioned, arose from reports of delayed gastric emptying and pulmonary aspiration following induction of anesthesia in patients using GLP-1 RAs. Although preoperative medication guidelines can prevent complications,withholding medications can also result in adverse effects. Furthermore, associated logistical burdens can result in surgical cancellations, significant care delays, and financial losses from unused operating room time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, University of North Carolina, Chapel Hill.
Zitieren
APA
Levi, M. (2024). Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications. JAMA. https://doi.org/10.1001/jama.2024.10023
Vancouver
Levi M. Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications. JAMA. 2024. doi:10.1001/jama.2024.10023
BibTeX
@article{Levi2024,
author = {Levi, Marc},
title = {Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.10023}
}
EUVIMED